Golombick, T., Diamond, T.H., Manoharan, A., Ramakrishna R. 2017. B-Cell Disorders and Curcumin. Integrative Cancer Therapies. 16(3): 255-257
Golombick, T., Diamond, T.H., Manoharan, A., Ramakrishna, R. 2015. Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients with Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study. Integrative Cancer Therapies. 15(2): 183-189
Ramakrishna, R., Rehman, A., Ramakrishna, S., Alexander, W., Yeo, W.W. 2015. Use of romiplostim in patients with chronic idiopathic thrombocytopenic purpura during perioperative period. Internal Medicine Journal. 45(7): 718- 724
Golombick, T., Diamond, T., Manoharan, A., Ramakrishna, R. Golombick, T., Diamond, T., Manoharan, A., Ramakrishna,R. 2015. The Effect of Curcumin (as Meriva) on Absolute Lymphocyte Count (ALC), NK Cells and T Cell Populations in Patients with Stage 0/1 Chronic Lymphocytic Leukemia. Journal of Cancer Therapy. 6:566-571.5.
Pota, H. R., Ramakrishna, R. 2015. A Flexible Pressure Controller for a Portable Multi-Chamber Therapeutic Device. International Journal of Bioinformatics and Biomedical Engineering 1 (3): 272-2756
Ramakrishna, R., Sarathy, K., Sarathy, T. 2013. Rituximab therapy in cutaneous infiltration of chronic lymphocytic leukaemia. Acta Haematologica. 130(1 ):47-517. Ramakrishna, R., Gupta, S., Sarathy, K., Bowen, A. 2013. Phenotypic and clinical manifestations of compound heterozygous genetic haemochromatosis (CHGH): A noninvasive approach to clinical management. Internal Medicine Journal. 43(3):254-2618.
Golombick, T., Diamond, T., Manoharan, A., Ramakrishna,R. 2012. Response to Vermorken et al – curcumin and free light chains. American Journal of Hematology. 87(10): E80- E81
Golombick, T., Diamond, T.H., Manoharan, A., Ramakrishna, R. 2012. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double-blind placebocontrolled cross-over 4g study and an open-label 8g extension study. American Journal of Hematology. 87(5) :455-460
Other roles
Haematologist, Illawarra Private Cancer Care Centre (IPCCC) and Southern Sydney Haematology Services (SSHS)